|
|
|
2003 Neurotech Leaders Forum
September 9, 2003
Agenda
| 8:30-9:00 |
Registration and Coffee |
| 9:00-9:15 |
The Market for Neurotechnology
James Cavuoto, Editor and Publisher, Neurotech
Reports |
| 9:15-9:30 |
Keynote Address: "Neurotechnology:
The User's Perspective"
Jennifer French, STIM Society
|
| 9:30-10:15 |
Neurostimulation
Market Opportunities
This session looks at some of the latest technological innovations
in neurostimulation, including applications in treating Parkinson's
disease, stroke, urinary incontinence, and pain.
Moderator:
Warren Grill, Ph.D., Case Western Reserve University, Neurotech
Reports
Panelists:
Geoffrey Thrope, CEO, NDI Medical
Philip Kennedy, M.D., PhD., President, Neural Signals Inc.
Gerald Loeb, M.D., Ph.D., AMI/University of Southern California |
| 10:15-10:30 |
Coffee Break |
| 10:30-11:15 |
Neurodiagnostics Market Opportunities
This session examines market opportunities,
competitive outlook, and technological advances in neurodiagnostics,
including applications in epilepsy, sleep apnea, and psychiatric
disorders.
Moderator:
James Cavuoto, Editor and Publisher,
Neurotech Reports
Panelists:
Jon Joseph, Ph.D., Vice-President, Nicolet Biomedical/Viasys Healthcare
Alan Gevins, Ph.D., President, SAM Technology
Chris Berka, CEO, Advanced Brain Monitoring, Inc.
Robert Pickar, President, TechMarket Research
|
| 11:15-12:00 |
Neurotechnology
Capital Markets
This session looks at the current outlook for venture capital funding
for neurotech devices and related technologies. A panel of venture
capital professionals will offer their insight on recent activity,
competition for funds, and factors leading to funding decisions.
Moderator:
James Cavuoto, Editor and Publisher,
Neurotech Reports
Panelists:
Konstantinos Alataris, Ph.D., Bay City Capital
Heath Lukatch, Ph.D., Piper Jaffrey Ventures
Roger Quy, Ph.D., Technology Partners
Daniel O'Connell, NeuroVentures Capital |
| 12:00-1:30 |
Luncheon, Sponsored by Quallion
LLC
Wendy Fong, Quallion LLC |
| 1:30-3:00 |
Entrepreneur Panel
This session features presentations from CEOs and founders of several
key neurotechnology start-up firms and more established technology
ventures. Each executive will present an overview of their firm's
technology and markets and the outlook for growth.
Moderator:
James Cavuoto, Editor and Publisher,
Neurotech Reports
Entrepreneurs:
Jason Harry, CEO, Afferent
Corp., Providence, RI
Scott Corbett, CEO, Advanced Cochlear
Systems, Snoqualmie, WA
Timothy Surgenor, CEO, Cyberkinetics,
Inc., Providence, RI
Steve Michelson, CEO, Cyclotec
AMT, Lauderhill, FL
Alan Olsen, CEO, Robomedica,
Inc., Culver City, CA
Lee Cuthbert, CEO, Intelli-Scents,
San Francisco, CA
|
| 3:00-3:15 |
Refreshment Break |
| 3:15-4:00 |
Neurotechnology Spinoffs
This session looks at the benefits and issues involved with spinning
off university neurotechnology research into commercial endeavors.
Several examples of recent successful spinoffs will be discussed,
with a critical examination of the risks and rewards associated
with university/industry collaboration.
Moderator:
Warren Grill, Ph.D., Case Western Reserve University, Neurotech
Reports
Panelists:
Yitzhak Zilberman, Ph.D., Alfred Mann Foundation
Scott Corbett, Advanced Cochlear Systems
|
| 4:00-5:00 |
Roundtable
Discussion: The Neurotechnology Industry of 2010
This wrap-up session involves the forum's presenters, panelists, and
attendees in an interactive and free-form discussion on the future
of the neurotechnology industry. Topics to be considered include technology
directions, competitiion from other industries, likely mergers and
acquisition activity, funding issues, user requirements, and public
awareness.
Moderator:
James Cavuoto, Editor and Publisher, Neurotech
Reports |
| 5:00-6:30 |
Cocktail Reception |
| |
|
|
